Salman Fazal, MD, West Penn Hospital
Advertisement
Articles by Salman Fazal, MD, West Penn Hospital
Advertisement
Latest Updated Articles
Standard of Care for BPDCN TreatmentPublished: August 20th 2020 | Updated:
Novel Agents for BPDCN ManagementPublished: August 20th 2020 | Updated:
Treatment Approach Amid COVID-19 PandemicPublished: August 20th 2020 | Updated:
Second-Line Treatment OptionsPublished: August 20th 2020 | Updated:
BPDCN Prevalence, Patient Profile, and Work-UpPublished: August 20th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
4
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
5